Ionizing radiation and hematopoietic malignancies: Altering the adaptive landscape

Cell Cycle

Volumn 9, Issue 15, 2010, Pages 3077-3083

  Fleenor, Courtney J ^a   Marusyk, Andriy ^a,b   DeGregori, James ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Evolution; Fitness; Hematopoietic; Irradiation; Notch; p53

Indexed keywords

NOTCH1 RECEPTOR; PROTEIN INTRACELLULAR NOTCH1; PROTEIN P53; TUMOR PROMOTER; UNCLASSIFIED DRUG;

CANCER INHIBITION; CARCINOGENESIS; CELL POPULATION; CLONE; EPIGENETICS; FITNESS; HEMATOPOIETIC STEM CELL; HUMAN; IONIZING RADIATION; IRRADIATION; MICROENVIRONMENT; MUTAGENIC ACTIVITY; MUTATIONAL ANALYSIS; NEOPLASM; NONHUMAN; PHENOTYPE; RADIATION EXPOSURE; RADIATION PROTECTION; REVIEW; RISK ASSESSMENT; STEM CELL; TUMOR GROWTH;

EID: 77956858165     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.9.15.12311     Document Type: Review

References (47)

1. Finch SC. Radiation-induced leukemia: Lessons from history. Best Pract Res Clin Haematol 2007; 20:109-18.
2. Little JB. Radiation carcinogenesis. Carcinogenesis 2000; 21:397-404.
3. Ron E. Ionizing radiation and cancer risk: evidence from epidemiology. Radiat Res 1998; 150:30-41.
4. Curtis RE, Rowlings PA, Deeg HJ, Shriner DA, Socie G, Travis LB, et al. Solid cancers after bone marrow transplantation. N Engl J Med 1997; 336:897-904. (Pubitemid 27137189)
5. Mody R, Li S, Dover DC, Sallan S, Leisenring W, Oeffinger KC, et al. Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. Blood 2008; 111:5515-23. (Pubitemid 351574084)
6. Kominami R, Niwa O. Radiation carcinogenesis in mouse thymic lymphomas. Cancer Sci 2006; 97:575-81. (Pubitemid 44056604)
7. Barcellos-Hoff MH, Park C, Wright EG. Radiation and the microenvironment - tumorigenesis and therapy. Nat Rev Cancer 2005; 5:867-75.
8. Rzeszowska-Wolny J, Przybyszewski WM, Widel M. Ionizing radiation-induced bystander effects, potential targets for modulation of radiotherapy. Eur J Pharmacol 2009; 625:156-64.
9. Sieber OM, Tomlinson SR, Tomlinson IP. Tissue, cell and stage specificity of (epi)mutations in cancers. Nat Rev Cancer 2005; 5:649-55.
10. Khare A, Shaulsky G. First among equals: competition between genetically identical cells. Nat Rev Genet 2006; 7:577-83. (Pubitemid 44081143)
11. Bondar T, Medzhitov R. p53-mediated hematopoietic stem and progenitor cell competition. Cell Stem Cell 6:309-22.
12. Marusyk A, Casas-Selves M, Henry CJ, Zaberezhnyy V, Klawitter J, Christians U, et al. Irradiation alters selection for oncogenic mutations in hematopoietic progenitors. Cancer Res 2009; 69:7262-9.
13. Wang Y, Schulte BA, LaRue AC, Ogawa M, Zhou D. Total body irradiation selectively induces murine hematopoietic stem cell senescence. Blood 2006; 107:358-66. (Pubitemid 43053564)
14. Muela A, Garcia-Bringas JM, Arana II, Barcina II. The Effect of Simulated Solar Radiation on Escherichia coli: The Relative Roles of UV-B, UV-A and Photosynthetically Active Radiation. Microb Ecol 2000; 39:65-71.
15. Nijnik A, Woodbine L, Marchetti C, Dawson S, Lambe T, Liu C, et al. DNA repair is limiting for haematopoietic stem cells during ageing. Nature 2007; 447:686-90.
16. Reese JS, Liu L, Gerson SL. Repopulating defect of mismatch repair-deficient hematopoietic stem cells. Blood 2003; 102:1626-33. (Pubitemid 37022553)
17. Rossi DJ, Bryder D, Seita J, Nussenzweig A, Hoeijmakers J, Weissman IL. Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature 2007; 447:725-9. (Pubitemid 46889729)
18. Kusunoki Y, Hayashi T. Long-lasting alterations of the immune system by ionizing radiation exposure: implications for disease development among atomic bomb survivors. Int J Radiat Biol 2008; 84:1-14. (Pubitemid 350208779)
19. Wong FL, Yamada M, Tominaga T, Fujiwara S, Suzuki G. Effects of radiation on the longitudinal trends of hemoglobin levels in the Japanese atomic bomb survivors. Radiat Res 2005; 164:820-7. (Pubitemid 41692730)
20. Godekmerdan A, Ozden M, Ayar A, Gursu MF, Ozan AT, Serhatlioglu S. Diminished cellular and humoral immunity in workers occupationally exposed to low levels of ionizing radiation. Arch Med Res 2004; 35:324-8. (Pubitemid 39119365)
21. Marusyk A, DeGregori J. Declining cellular fitness with age promotes cancer initiation by selecting for adaptive oncogenic mutations. Biochim Biophys Acta 2008; 1785:1-11. (Pubitemid 350192081)
22. Bilousova G, Marusyk A, Porter CC, Cardiff RD, DeGregori J. Impaired DNA replication within progenitor cell pools promotes leukemogenesis. PLoS Biol 2005; 3:401.
23. Marusyk A, Porter CC, Zaberezhnyy V, DeGregori J. Irradiation selects for p53-deficient hematopoietic progenitors. PLoS Biol 2010; 8:1000324.
24. Duncan AW, Rattis FM, DiMascio LN, Congdon KL, Pazianos G, Zhao C, et al. Integration of Notch and Wnt signaling in hematopoietic stem cell maintenance. Nat Immunol 2005; 6:314-22. (Pubitemid 41724769)
25. Stier S, Cheng T, Dombkowski D, Carlesso N, Scadden DT. Notch1 activation increases hematopoietic stem cell self-renewal in vivo and favors lymphoid over myeloid lineage outcome. Blood 2002; 99:2369-78. (Pubitemid 34525422)
26. Varnum-Finney B, Xu L, Brashem-Stein C, Nourigat C, Flowers D, Bakkour S, et al. Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive Notch1 signaling. Nat Med 2000; 6:1278-81.
27. Weng AP, Ferrando AA, Lee W, Morris JPt, Silverman LB, Sanchez-Irizarry C, et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 2004; 306:269-71. (Pubitemid 39336870)
28. Tsuji H, Ishii-Ohba H, Ukai H, Katsube T, Ogiu T. Radiation-induced deletions in the 5′ end region of Notch1 lead to the formation of truncated proteins and are involved in the development of mouse thymic lymphomas. Carcinogenesis 2003; 24:1257-68. (Pubitemid 36927067)
29. Laconi S, Pani P, Pillai S, Pasciu D, Sarma DS, Laconi E. A growth-constrained environment drives tumor progression invivo. Proc Natl Acad Sci USA 2001; 98:7806-11. (Pubitemid 32642642)
30. Bakker J, Wilson S. Using ecological restoration to constrain biological invasion. Journal of Applied Ecology 2004; 41:1058-64. (Pubitemid 40033194)
31. Blagosklonny MV. Oncogenic resistance to growth-limiting conditions. Nat Rev Cancer 2002; 2:221-5.
32. Laconi E, Doratiotto S, Vineis P. The microenvironments of multistage carcinogenesis. Semin Cancer Biol 2008; 18:322-9.
33. Merlo LM, Pepper JW, Reid BJ, Maley CC. Cancer as an evolutionary and ecological process. Nat Rev Cancer 2006; 6:924-35.
34. Thilly WG. Have environmental mutagens caused oncomutations in people? Nat Genet 2003; 34:255-9.
35. Junttila MR, Evan GI. p53 - a Jack of all trades but master of none. Nat Rev Cancer 2009; 9:821-9.
36. Wallace-Brodeur RR, Lowe SW. Clinical implications of p53 mutations. Cell Mol Life Sci 1999; 55:64-75.
37. Soussi T, Wiman KG. Shaping genetic alterations in human cancer: the p53 mutation paradigm. Cancer Cell 2007; 12:303-12. (Pubitemid 47539312)
38. Green DR. Cell competition: pirates on the tangled bank. Cell Stem Cell 6:287-8.
39. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA Jr, Butel JS, et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 1992; 356:215-21.
40. Harvey M, McArthur MJ, Montgomery CA Jr, Butel JS, Bradley A, Donehower LA. Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nat Genet 1993; 5:225-9. (Pubitemid 23330383)
41. Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, Bronson RT, et al. Tumor spectrum analysis in p53-mutant mice. Curr Biol 1994; 4:1-7. (Pubitemid 2027671)
42. Kemp CJ, Wheldon T, Balmain A. p53-deficient mice are extremely susceptible to radiation-induced tumorigenesis. Nat Genet 1994; 8:66-9.
43. Christophorou MA, Ringshausen I, Finch AJ, Swigart LB, Evan GI. The pathological response to DNA damage does not contribute to p53-mediated tumour suppression. Nature 2006; 443:214-7.
44. Hinkal G, Parikh N, Donehower LA. Timed somatic deletion of p53 in mice reveals age-associated differences in tumor progression. PLoS One 2009; 4:6654.
45. Rodier F, Coppe JP, Patil CK, Hoeijmakers WA, Munoz DP, Raza SR, et al. Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat Cell Biol 2009; 11:973-9.
46. Gatenby RA, Gillies RJ. A microenvironmental model of carcinogenesis. Nat Rev Cancer 2008; 8:56-61.
47. Lowe SW, Cepero E, Evan G. Intrinsic tumour suppression. Nature 2004; 432:307-15.